Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma

J Clin Oncol. 2015 Nov 20;33(33):e122-4. doi: 10.1200/JCO.2013.51.1683. Epub 2014 Apr 28.
No abstract available

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Chemotherapy, Adjuvant
  • Female
  • Follow-Up Studies
  • Humans
  • Ipilimumab
  • Melanoma / drug therapy*
  • Melanoma / pathology*
  • Melanoma / surgery
  • Methylprednisolone / therapeutic use
  • Myasthenia Gravis / chemically induced*
  • Myasthenia Gravis / physiopathology
  • Myasthenia Gravis / therapy
  • Plasmapheresis / methods
  • Risk Assessment
  • Sampling Studies
  • Severity of Illness Index
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / surgery
  • Survival Rate
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Ipilimumab
  • Methylprednisolone